共 50 条
- [1] Cost-effectiveness analysis of etanercept monotherapy versus infliximab plus methotrexate in the treatment of rheumatoid arthritis. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S322 - S322
- [2] Infliximab and etanercept treatment in rheumatoid arthritis. A Swedish experience. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S227 - S227
- [4] Cost effectiveness of infliximab in rheumatoid arthritis. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S144 - S144
- [5] The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S538 - S538
- [6] Cost-efficacy comparison of adalimumab and etanercept in the treatment of rheumatoid arthritis. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S461 - S461
- [7] Cost-effectiveness analysis of etanercept versus infliximab and anakinra in the treatment of rheumatoid arthritis in italy. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S460 - S461
- [8] Cost effectiveness analysis of etanercept (ENBREL) versus infliximab (Remicade) in the treatment of rheumatoid arthritis patients. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S95 - S95
- [10] A difference in effectiveness between infliximab, etanercept and adalimumab in patients with rheumatoid arthritis. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S309 - S310